Protein binding methotrexate derivatives and medicaments containing them
DE102006033837A1
Concentrated methotrexate solutions
CN1615301A
Dithiocarbamate derivatives and their use as antibacterial agents
DE10237146A1
Use of treosulfan and derivatives thereof for the treatment of multiple sclerosis
DE10063076A1
Use of 5-aminolevulinic acid for restenosis prophylaxis
DE10034673C1
Dermal application system for aminolevulinic acid and its use
AU2762700A
Pharmaceutical nanosuspensions for medicament administration as systems of increased saturation solubility and rate of solution
DE19957371A1
Mitomycin C solution
DE19953517C1
Use of treosulfan to condition patients prior to bone marrow transplant or blood stem cell transplant
EP1077711A2
Treatment of papilloma virus infection using a mycobacterium
DE19744811A1
Use of delta-aminolevulinic acid for the production of a topical medicament for the integral diagnosis and / or therapy of tumors in hollow organs
AU3982795A
Pharmaceutical nanosuspensions for medicament administration as systems of increased saturation solubility and rate of solution
DE19543039C1
DNA mols. encoding CD30-specific immunoglobulin variable regions
DE19502662C1
Continuous infusion instrument into urinary bladder
DE4446698A1
Microtiter plate with a means for indicating the filling status, production of a microtiter plate and use of a pH indicator
WO9404189A1
Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
AU3347293A
Expression signal-peptide-free staphylokinases
EP0613497A1
Lymphoid cd30-antigen
DE4228106A1
Tumour diagnosis and treatment in organs, esp. urinary system - comprises admin. of gamma-amino-levulinic acid as photosensitiser, detection, and treatment by irradiation with neodymium-yttrium-aluminium-garnet laser
DE4205938A1
New immuno-toxin contg. CD30 monoclonal antibody - is coupled to type 1 ribosome inactivating protein toxin, for selective elimination of CD30 cells, esp. treatment of Hodgkins disease
